Distinct distribution patterns of exercise-induced natural killer cell mobilization into the circulation and tumor tissue of patients with prostate cancer.


Journal

American journal of physiology. Cell physiology
ISSN: 1522-1563
Titre abrégé: Am J Physiol Cell Physiol
Pays: United States
ID NLM: 100901225

Informations de publication

Date de publication:
01 09 2022
Historique:
pubmed: 2 8 2022
medline: 11 9 2022
entrez: 1 8 2022
Statut: ppublish

Résumé

The mobilization and activation of natural killer (NK) cells have been proposed as key mechanisms promoting anti-oncogenic effects of physical exercise. Although mouse models have proven that physical exercise recruits NK cells to tumor tissue and inhibits tumor growth, this preclinical finding has not been transferred to the clinical setting yet. In this first-in-human study, we found that physical exercise mobilizes and redistributes NK cells, especially those with a cytotoxic phenotype, in line with preclinical models. However, physical exercise did not increase NK cell tumor infiltrates. Future studies should carefully distinguish between acute and chronic exercise modalities and should be encouraged to investigate more immune-responsive tumor entities.

Identifiants

pubmed: 35912994
doi: 10.1152/ajpcell.00243.2022
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

C879-C884

Auteurs

Alexander Schenk (A)

Division of Performance and Health (Sports Medicine), Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.

Tobias Esser (T)

Division of Performance and Health (Sports Medicine), Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.

Sergen Belen (S)

Institute for molecular and cellular sports medicine, German Sport University Cologne, Cologne, Germany.

Nadira Gunasekara (N)

Institute for molecular and cellular sports medicine, German Sport University Cologne, Cologne, Germany.

Niklas Joisten (N)

Division of Performance and Health (Sports Medicine), Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.

Matteo Thomas Winker (MT)

Institute for molecular and cellular sports medicine, German Sport University Cologne, Cologne, Germany.

Lea Weike (L)

Institute of Sports Medicine, Paderborn University, Paderborn, Germany.

Wilhelm Bloch (W)

Institute for molecular and cellular sports medicine, German Sport University Cologne, Cologne, Germany.

Axel Heidenreich (A)

Faculty of Medicine, Department of Urology, Uro-Oncology, Robot-Assisted and Reconstructive Urology, University Hospital Cologne, Cologne, Germany.
Department of Urology, Medical University Vienna, Vienna, Austria.

Jan Herden (J)

Faculty of Medicine, Department of Urology, Uro-Oncology, Robot-Assisted and Reconstructive Urology, University Hospital Cologne, Cologne, Germany.

Heike Löser (H)

Institute of Pathology, University Hospital Cologne, Cologne, Germany.

Sabine Oganesian (S)

Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
Cancer- and Immunometabolism Research Group, LMU Gene Center, Munich, Germany.
German Cancer Consortium (DKTK), Munich Site, German Cancer Research Center, Heidelberg, Germany.

Sebastian Theurich (S)

Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
Cancer- and Immunometabolism Research Group, LMU Gene Center, Munich, Germany.
German Cancer Consortium (DKTK), Munich Site, German Cancer Research Center, Heidelberg, Germany.

Carsten Watzl (C)

Department for Immunology, Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund University (IfADo), Dortmund, Germany.

Philipp Zimmer (P)

Division of Performance and Health (Sports Medicine), Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH